Literature DB >> 15905554

Differential immunogenicity of two peptides isolated by high molecular weight-melanoma-associated antigen-specific monoclonal antibodies with different affinities.

Wei Luo1, Jeff Chi-feng Hsu, Chun-yen Tsao, Eric Ko, Xinhui Wang, Soldano Ferrone.   

Abstract

Peptide mimics isolated from phage display peptide libraries by panning with self-tumor-associated Ag (TAA)-specific mAbs are being evaluated as immunogens to implement active specific immunotherapy. Although TAA-specific mAb are commonly used to isolate peptide mimics, no information is available regarding the Ab characteristics required to isolate immunogenic TAA peptide mimics. To address this question, we have used mAb 763.74 and mAb GH786, which recognize the same or spatially close antigenic determinant(s) of the human high m.w.-melanoma-associated Ag (HMW-MAA), although with different affinity. mAb 763.74 affinity is higher than that of mAb GH786. Panning of phage display peptide libraries with mAb 763.74 and mAb GH786 resulted in the isolation of peptides P763.74 and PGH786, respectively. When compared for their ability to induce HMW-MAA-specific immune responses in BALB/c mice, HMW-MAA-specific Ab titers were significantly higher in mice immunized with P763.74 than in those immunized with PGH786. The HMW-MAA-specific Ab titers were markedly increased by a booster with HMW-MAA-bearing melanoma cells, an effect that was significantly higher in mice primed with P763.74 than in those primed with PGH786. Lastly, P763.74, but not PGH786, induced a delayed-type hypersensitivity response to HMW-MAA-bearing melanoma cells. These findings suggest that affinity for TAA is a variable to take into account when selecting mAb to isolate peptide mimics from a phage display peptide library.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905554     DOI: 10.4049/jimmunol.174.11.7104

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigen.

Authors:  A Barucca; M Capitani; M Cesca; D Tomassoni; U Kazmi; F Concetti; L Vincenzetti; A Concetti; F M Venanzi
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

2.  Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients.

Authors:  Fabio Morandi; Maria Valeria Corrias; Isabella Levreri; Paola Scaruffi; Lizzia Raffaghello; Barbara Carlini; Paola Bocca; Ignazia Prigione; Sara Stigliani; Loredana Amoroso; Soldano Ferrone; Vito Pistoia
Journal:  Cancer Immunol Immunother       Date:  2011-06-10       Impact factor: 6.968

3.  CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.

Authors:  Xinhui Wang; Takuya Osada; Yangyang Wang; Ling Yu; Koichi Sakakura; Akihiro Katayama; James B McCarthy; Adam Brufsky; Mamatha Chivukula; Thaer Khoury; David S Hsu; William T Barry; H Kim Lyerly; Timothy M Clay; Soldano Ferrone
Journal:  J Natl Cancer Inst       Date:  2010-09-17       Impact factor: 13.506

4.  Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.

Authors:  Chun-Yen Tsao; Francesco Sabbatino; Nai-Kong V Cheung; Jeff Chi-Feng Hsu; Vincenzo Villani; Xinhui Wang; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

5.  CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Authors:  Valeria Leuci; Chiara Donini; Giovanni Grignani; Ramona Rotolo; Giulia Mesiano; Erika Fiorino; Loretta Gammaitoni; Lorenzo D'Ambrosio; Alessandra Merlini; Elisa Landoni; Enzo Medico; Sonia Capellero; Lidia Giraudo; Giulia Cattaneo; Ilenia Iaia; Ymera Pignochino; Marco Basiricò; Elisa Vigna; Alberto Pisacane; Franca Fagioli; Soldano Ferrone; Massimo Aglietta; Gianpietro Dotti; Dario Sangiolo
Journal:  Clin Cancer Res       Date:  2020-09-08       Impact factor: 12.531

6.  Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells.

Authors:  Craig A Cooney; Fariba Jousheghany; Aiwei Yao-Borengasser; Bounleut Phanavanh; Tina Gomes; Ann Marie Kieber-Emmons; Eric R Siegel; Larry J Suva; Soldano Ferrone; Thomas Kieber-Emmons; Behjatolah Monzavi-Karbassi
Journal:  Breast Cancer Res       Date:  2011-06-09       Impact factor: 6.466

Review 7.  Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.

Authors:  Kyriakos A Hassapis; Dora C Stylianou; Leondios G Kostrikis
Journal:  Viruses       Date:  2014-12-17       Impact factor: 5.048

8.  The development of inovirus-associated vector vaccines using phage-display technologies.

Authors:  Zachariah Stern; Dora C Stylianou; Leondios G Kostrikis
Journal:  Expert Rev Vaccines       Date:  2019-09-08       Impact factor: 5.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.